Skip to content

Altria's $90B market surge masks earnings miss and regulatory storms

A 20% rally can't hide the cracks: Altria's latest earnings stumble and EU crackdowns test investor loyalty. Will the 6.5% dividend be enough to hold them?

The image shows a stock market chart with a white background and text at the top. The chart is a...
The image shows a stock market chart with a white background and text at the top. The chart is a forex indicator with a red arrow pointing up and a green arrow pointing down, indicating a potential reversal in the stock market.

Altria's $90B market surge masks earnings miss and regulatory storms

Altria, the tobacco giant, has seen its market value climb by roughly 20% since early 2024. The company now holds a market capitalisation of around $90 billion, outperforming Philip Morris but trailing behind British American Tobacco. Meanwhile, its latest financial results missed expectations, and regulatory hurdles in Europe are adding pressure.

Despite these challenges, the stock remains up about 15% this year alone, drawing mixed reactions from investors.

Altria's latest quarterly report showed earnings per share of $1.30, slightly below forecasts. Revenue also dipped by 0.5% compared to the same period last year. These figures have led some investors to reassess their positions.

Major asset managers are making notable adjustments. Mainstay Capital Management, Wilmington Savings Fund Society, and Swiss Life Asset Management have all cut their stakes in the company. In contrast, Stillwater Wealth Management Group opened a new position worth approximately $1.52 million. These shifts come just before the ex-dividend date on March 25, with the payout of $1.06 per share due on April 30.

The dividend yield stands at about 6.5%, an attractive figure for income investors. However, the payout ratio exceeds 103%, raising concerns about long-term sustainability. The stock's relative strength index (RSI) of 76.9 suggests it may be overbought, adding to the caution among some shareholders.

Regulatory issues are also mounting. In Spain, Altria faces fresh challenges, while illicit tobacco trade is surging in markets like Belgium. Untaxed and counterfeit products made up over 44% of total consumption there in the final quarter of 2025. These factors could further strain the company's performance in key regions.

Since January 2024, Altria's market capitalisation has grown from $75 billion to $90 billion. While this growth outpaces Philip Morris International's 15% increase, it lags behind British American Tobacco's 25% rise over the same period.

Altria's next key date is the ex-dividend deadline on March 25, followed by the payout on April 30. Investors will watch closely as the company navigates financial pressures, regulatory setbacks, and shifting market dynamics. The stock's recent gains and high dividend yield continue to draw interest, but risks remain.

Read also:

Latest